7 juin 2023
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.830.1132
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37283382
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_74860F866DE80
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-12-07 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
C.A. Baud et al., « Contrats thérapeutiques et traitements agonistes opioïdes : juridiquement et éthiquement discutables [Therapeutic contracts and opioid agonist treatments: legally and ethically questionable] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.830.1132
In Switzerland, the use of « therapeutic contracts » in the implementation of opioid agonist treatments (OAT) is frequently recommended or even imposed. These documents raise legal and ethical issues, which are presented in this article. The authors recommend that this practice be abandoned. The usual tools of medical treatments (e.g. information document, treatment plan) are sufficient.